JP2012240995A - Zinc oxide dispersion and cosmetic - Google Patents
Zinc oxide dispersion and cosmetic Download PDFInfo
- Publication number
- JP2012240995A JP2012240995A JP2011115519A JP2011115519A JP2012240995A JP 2012240995 A JP2012240995 A JP 2012240995A JP 2011115519 A JP2011115519 A JP 2011115519A JP 2011115519 A JP2011115519 A JP 2011115519A JP 2012240995 A JP2012240995 A JP 2012240995A
- Authority
- JP
- Japan
- Prior art keywords
- zinc oxide
- particles
- treatment
- silicone
- dispersion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 title claims abstract description 237
- 239000002537 cosmetic Substances 0.000 title claims description 34
- 239000002245 particle Substances 0.000 claims abstract description 114
- 239000011787 zinc oxide Substances 0.000 claims abstract description 94
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 64
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 57
- 239000011247 coating layer Substances 0.000 claims abstract description 35
- 229910052814 silicon oxide Inorganic materials 0.000 claims abstract description 25
- 239000007788 liquid Substances 0.000 claims abstract description 13
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 36
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 34
- 239000000377 silicon dioxide Substances 0.000 claims description 15
- 239000002270 dispersing agent Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 8
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 abstract description 22
- 239000006185 dispersion Substances 0.000 abstract description 20
- 238000009472 formulation Methods 0.000 abstract description 5
- -1 for example Substances 0.000 description 41
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 40
- 239000000284 extract Substances 0.000 description 38
- 239000010410 layer Substances 0.000 description 28
- 239000003795 chemical substances by application Substances 0.000 description 22
- 239000002994 raw material Substances 0.000 description 20
- 235000014113 dietary fatty acids Nutrition 0.000 description 19
- 239000000194 fatty acid Substances 0.000 description 19
- 229930195729 fatty acid Natural products 0.000 description 19
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 17
- 239000011324 bead Substances 0.000 description 17
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 16
- 239000011164 primary particle Substances 0.000 description 16
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 14
- 239000004205 dimethyl polysiloxane Substances 0.000 description 14
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 14
- 229920001577 copolymer Polymers 0.000 description 13
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 12
- 150000004665 fatty acids Chemical class 0.000 description 11
- 230000003472 neutralizing effect Effects 0.000 description 11
- 230000008719 thickening Effects 0.000 description 11
- 239000000843 powder Substances 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 9
- 238000004381 surface treatment Methods 0.000 description 9
- 238000004438 BET method Methods 0.000 description 8
- 241001561902 Chaetodon citrinellus Species 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 239000004359 castor oil Substances 0.000 description 8
- 235000019438 castor oil Nutrition 0.000 description 8
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 8
- 235000010746 mayonnaise Nutrition 0.000 description 8
- 239000008268 mayonnaise Substances 0.000 description 8
- 239000003973 paint Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 150000001343 alkyl silanes Chemical class 0.000 description 6
- 239000007900 aqueous suspension Substances 0.000 description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000010954 inorganic particle Substances 0.000 description 5
- 235000019388 lanolin Nutrition 0.000 description 5
- 229940039717 lanolin Drugs 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 239000010936 titanium Substances 0.000 description 5
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940092738 beeswax Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229910052761 rare earth metal Inorganic materials 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000001593 sorbitan monooleate Substances 0.000 description 3
- 229940035049 sorbitan monooleate Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 238000003917 TEM image Methods 0.000 description 2
- 229920002359 Tetronic® Polymers 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium(3+);trinitrate Chemical compound [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 125000006353 oxyethylene group Chemical group 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 229940012831 stearyl alcohol Drugs 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229910052718 tin Inorganic materials 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- OERNJTNJEZOPIA-UHFFFAOYSA-N zirconium nitrate Chemical compound [Zr+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O OERNJTNJEZOPIA-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- CWLGEPSKQDNHIO-JOBJLJCHSA-N (e)-n-[(e)-benzylideneamino]-1-phenylmethanimine Chemical compound C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1 CWLGEPSKQDNHIO-JOBJLJCHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- ZXNAIPHYBVMMPY-KTKRTIGZSA-N 1-erucoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC(O)CO ZXNAIPHYBVMMPY-KTKRTIGZSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- QQXJNLYVPPBERR-UHFFFAOYSA-N 1-phenyldecan-1-one Chemical compound CCCCCCCCCC(=O)C1=CC=CC=C1 QQXJNLYVPPBERR-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- ZUACFBHNVKYJFQ-UHFFFAOYSA-N 2-tert-butyl-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)C(=O)C1=CC=CC=C1 ZUACFBHNVKYJFQ-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- URDOJQUSEUXVRP-UHFFFAOYSA-N 3-triethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CCO[Si](OCC)(OCC)CCCOC(=O)C(C)=C URDOJQUSEUXVRP-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- JOKBLKCZHGIRNO-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(C(=O)C=2C=CC=CC=2)=C1 JOKBLKCZHGIRNO-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 229910052779 Neodymium Inorganic materials 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004111 Potassium silicate Substances 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- KILYNHHCRKVDRU-UHFFFAOYSA-N [S].C1CC2(C)C(=O)CC1C2(C)C Chemical compound [S].C1CC2(C)C(=O)CC1C2(C)C KILYNHHCRKVDRU-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229940105017 achillea millefolium extract Drugs 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- HXLXCTGYNUQAIY-UHFFFAOYSA-M aluminum oxygen(2-) titanium(4+) hydroxide Chemical compound [O-2].[Al+3].[OH-].[Ti+4] HXLXCTGYNUQAIY-UHFFFAOYSA-M 0.000 description 1
- ANBBXQWFNXMHLD-UHFFFAOYSA-N aluminum;sodium;oxygen(2-) Chemical compound [O-2].[O-2].[Na+].[Al+3] ANBBXQWFNXMHLD-UHFFFAOYSA-N 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- FAPDDOBMIUGHIN-UHFFFAOYSA-K antimony trichloride Chemical compound Cl[Sb](Cl)Cl FAPDDOBMIUGHIN-UHFFFAOYSA-K 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229940073663 methyl trimethicone Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- MSRJTTSHWYDFIU-UHFFFAOYSA-N octyltriethoxysilane Chemical compound CCCCCCCC[Si](OCC)(OCC)OCC MSRJTTSHWYDFIU-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- ZBVQEUUTPTVMHY-UHFFFAOYSA-N phenyl-(2-phenylphenyl)methanone Chemical compound C=1C=CC=C(C=2C=CC=CC=2)C=1C(=O)C1=CC=CC=C1 ZBVQEUUTPTVMHY-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 229910052913 potassium silicate Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000001819 propan-2-yl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- VZKNAUXVJXVEAG-UHFFFAOYSA-N propan-2-yl hexadecanoate;propan-2-yl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C.CCCCCCCCCCCCCCCC(=O)OC(C)C VZKNAUXVJXVEAG-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910001388 sodium aluminate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- RSNQKPMXXVDJFG-UHFFFAOYSA-N tetrasiloxane Chemical compound [SiH3]O[SiH2]O[SiH2]O[SiH3] RSNQKPMXXVDJFG-UHFFFAOYSA-N 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229910000349 titanium oxysulfate Inorganic materials 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- XOALFFJGWSCQEO-UHFFFAOYSA-N tridecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCOC(=O)C=C XOALFFJGWSCQEO-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical class CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- ZXAUZSQITFJWPS-UHFFFAOYSA-J zirconium(4+);disulfate Chemical compound [Zr+4].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZXAUZSQITFJWPS-UHFFFAOYSA-J 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、酸化亜鉛分散体及びそれを配合して得られた化粧料に関するものである。 The present invention relates to a zinc oxide dispersion and a cosmetic obtained by blending it.
酸化亜鉛、酸化チタン等の各種の無機粉体は、液状シリコーン及び分散剤を含有する基材を調製し、このような分散体を化粧料調製用の原料として配合することによって化粧料を調製することが行われている(特許文献1,2)。これによって、安定した高い分散安定性を有する酸化亜鉛分散体を得ることができるため、透明感があって自然な仕上がりが得られる化粧料を提供できるものである。 Various inorganic powders such as zinc oxide and titanium oxide are prepared by preparing a base material containing liquid silicone and a dispersant, and blending such a dispersion as a raw material for preparing the cosmetic material. (Patent Documents 1 and 2). Thus, a zinc oxide dispersion having a stable and high dispersion stability can be obtained, and thus a cosmetic that is transparent and has a natural finish can be provided.
化粧品分野において、酸化亜鉛粒子は紫外線遮蔽剤として使用されており、多くの化粧品において汎用されている原料である。このような酸化亜鉛粒子は、表面活性を抑制する目的で表面被覆を行ったものが広く使用されている(特許文献3)。 In the cosmetic field, zinc oxide particles are used as an ultraviolet shielding agent and are a widely used raw material in many cosmetics. As such zinc oxide particles, those coated with a surface for the purpose of suppressing surface activity are widely used (Patent Document 3).
このような酸化亜鉛粒子を液状シリコーン及び分散剤を含有する基材に配合した場合、処方によっては粘度の制御が困難となり、処方上の問題を生じることがある。特に、サンスクリーンで使用することの多い酸化チタンと併用した場合には、増粘という問題が生じやすく、処方設計がしにくいため、酸化亜鉛分散体と酸化チタン分散体のうち、より粘度が高い方の粘度が混合した際の粘度より低くならないことが好ましい。このような増粘という問題を改善するための検討は行われておらず、改良が求められていた。 When such zinc oxide particles are blended with a substrate containing liquid silicone and a dispersant, depending on the formulation, it is difficult to control the viscosity, which may cause a problem in formulation. In particular, when used in combination with titanium oxide, which is often used in sunscreens, the problem of thickening is likely to occur, and the formulation design is difficult, so the viscosity is higher among zinc oxide dispersion and titanium oxide dispersion. It is preferable that the viscosity of the one does not become lower than the viscosity when mixed. There has been no investigation for improving such a problem of thickening, and improvement has been demanded.
特許文献4,5には、特定の被覆を施した酸化亜鉛と特定の界面活性剤とを併用した化粧料組成物が開示されている。しかし、これらに記載された組成物は、粉体状態の酸化亜鉛を使用して調製されたものであり、酸化亜鉛を液体媒体中に分散させた分散体を調製することは記載されていない。 Patent Documents 4 and 5 disclose cosmetic compositions in which zinc oxide having a specific coating and a specific surfactant are used in combination. However, the compositions described in these are prepared using powdered zinc oxide, and there is no description of preparing a dispersion in which zinc oxide is dispersed in a liquid medium.
本発明は、上記に鑑み、処方によって増粘を生じやすいという問題を生じることがない酸化亜鉛分散体を提供することを目的とするものである。特に酸化チタンのシリコーン分散体と混合した際に従来の酸化亜鉛分散体では増粘するという問題があった。本発明は、このような問題の解決を図るものである。 An object of this invention is to provide the zinc oxide dispersion which does not produce the problem that it is easy to produce a viscosity increase by prescription in view of the above. In particular, the conventional zinc oxide dispersion has a problem of thickening when mixed with a titanium oxide silicone dispersion. The present invention is intended to solve such problems.
本発明者らは酸化チタンのシリコーン分散体と酸化亜鉛のシリコーン分散体を混合した際の増粘の機構について調査した結果、それが化学反応によって引き起こされるのではないことが分かった。 As a result of investigating the mechanism of thickening when mixing a titanium oxide silicone dispersion and a zinc oxide silicone dispersion, the inventors have found that it is not caused by a chemical reaction.
本発明は、表面にケイ素酸化物からなる被覆層を形成した酸化亜鉛粒子に対してシリコーン処理を施すことによって得られた粒子を液状シリコーン中に分散させたことを特徴とする酸化亜鉛分散体である。 The present invention relates to a zinc oxide dispersion characterized in that particles obtained by subjecting zinc oxide particles having a silicon oxide coating layer formed thereon to silicone treatment are dispersed in liquid silicone. is there.
上記酸化亜鉛分散体は、イソプロパノール分散中で測定したゼータ電位が−90mV以下である粒子を用いたものであることが好ましい。
上記ケイ素酸化物からなる被覆層は、被覆層を形成し、シリコーン処理を施した酸化亜鉛の重量に対して2〜50重量%であることが好ましい。
上記酸化亜鉛分散体は、更に、シリコーン系分散剤を含有することが好ましい。
上記酸化亜鉛分散体は、更に、酸化チタン粒子を含有するものであってもよい。
上記酸化チタン粒子は、アルミナ及び/又は水酸化アルミニウム処理及びシリコーン処理を施したものであることが好ましい。
The zinc oxide dispersion is preferably one using particles whose zeta potential measured in isopropanol dispersion is −90 mV or less.
The coating layer made of the silicon oxide is preferably 2 to 50% by weight with respect to the weight of the zinc oxide on which the coating layer is formed and subjected to the silicone treatment.
The zinc oxide dispersion preferably further contains a silicone-based dispersant.
The zinc oxide dispersion may further contain titanium oxide particles.
The titanium oxide particles are preferably those subjected to alumina and / or aluminum hydroxide treatment and silicone treatment.
本発明は、上述した酸化亜鉛分散体を配合して得られたことを特徴とする化粧料でもある。 The present invention is also a cosmetic obtained by blending the above-described zinc oxide dispersion.
本発明によって、増粘を生じることがない酸化亜鉛分散体を提供することができる。これによって、増粘の問題を生じることなく、酸化亜鉛を配合した化粧料を得ることができる。また、本発明者らは、酸化亜鉛粒子の表面をケイ素酸化物で処理し、表面電位を調整することによって、その増粘が抑制できることを発見し、本発明を完成するに至った。 According to the present invention, a zinc oxide dispersion that does not cause thickening can be provided. Thereby, a cosmetic containing zinc oxide can be obtained without causing the problem of thickening. Moreover, the present inventors discovered that the thickening can be suppressed by treating the surface of the zinc oxide particles with silicon oxide and adjusting the surface potential, and completed the present invention.
本発明は、表面にケイ素酸化物からなる被覆層を形成した酸化亜鉛粒子に対してシリコーン処理を施すことによって得られた粒子をシリコーンオイル中に分散させた酸化亜鉛分散体である。すなわち、液体媒体としてのシリコーンオイル中に酸化亜鉛を分散させたものである。このような酸化亜鉛分散体は、分散体として調製した後に、水その他の化粧料のその他の配合成分と混合することによって、化粧料を調製することができる。 The present invention is a zinc oxide dispersion in which particles obtained by applying silicone treatment to zinc oxide particles having a coating layer made of silicon oxide on the surface are dispersed in silicone oil. That is, zinc oxide is dispersed in silicone oil as a liquid medium. Such a zinc oxide dispersion can be prepared as a dispersion, and then mixed with water or other ingredients of cosmetics to prepare a cosmetic.
原料として使用することができる酸化亜鉛としては特に限定されず、フランス法、アメリカ法等の公知の方法によって製造された酸化亜鉛を使用することができるが、特に、フランス法によって製造された酸化亜鉛を使用することが不純物が少ない点で好ましい。また、炭酸塩などを加熱焼成するプレカーサー法によって得られた酸化亜鉛は粒子が細かい点からより好ましい。 Zinc oxide that can be used as a raw material is not particularly limited, and zinc oxide produced by a known method such as the French method or the American method can be used. In particular, zinc oxide produced by the French method can be used. Is preferable from the viewpoint of few impurities. In addition, zinc oxide obtained by a precursor method in which carbonate or the like is heated and fired is more preferable in terms of fine particles.
本発明において用いる酸化亜鉛粒子は、表面にケイ素酸化物からなる被覆層を形成して表面電位を変化させたものである。上記被覆層は、ケイ素酸化物による被覆及びシリコーン処理を行った後の酸化亜鉛粒子の重量に対して2〜50重量%、好ましくは、5〜20重量%の範囲でケイ素酸化物からなることが好ましい。上記ケイ素酸化物は、限定されるものではないが、好ましくは、含水ケイ素酸化物である。酸化亜鉛粒子におけるケイ素酸化物の割合が2重量%よりも少ないときは、酸化亜鉛粒子の表面電位の変化が十分でない場合があり、他方、50重量%を越えるときは、得られる酸化亜鉛粒子組成物中の酸化亜鉛濃度が薄くなるため紫外線遮蔽効果が不十分になってしまうおそれがある。 The zinc oxide particles used in the present invention are obtained by changing the surface potential by forming a coating layer made of silicon oxide on the surface. The coating layer is made of silicon oxide in the range of 2 to 50% by weight, preferably 5 to 20% by weight, based on the weight of the zinc oxide particles after the coating with silicon oxide and the silicone treatment. preferable. The silicon oxide is not limited, but is preferably a hydrous silicon oxide. When the proportion of silicon oxide in the zinc oxide particles is less than 2% by weight, the change in the surface potential of the zinc oxide particles may not be sufficient. On the other hand, when the proportion exceeds 50% by weight, the resulting zinc oxide particle composition Since the zinc oxide concentration in the product becomes thin, the ultraviolet shielding effect may be insufficient.
上記ケイ素酸化物からなる皮膜の形成方法としては、特に限定されるものではないが、具体的には以下に示すような方法を挙げることができる。
まず、原料酸化亜鉛粒子の水性懸濁液に、酸化亜鉛とSiO2の合計量に対してSiO2 として2〜50重量%の水溶性ケイ酸塩を加える。ついで、温度を60℃以上に保持しつつ、40分以上の時間をかけて酸を中和剤として加えて、pHが6.0〜8.0の範囲となるまで、懸濁液を中和することによって、酸化亜鉛粒子の表面にケイ素酸化物からなる高密度の被覆層を形成して、上記酸化亜鉛粒子を得ることができる。
A method for forming the film made of the silicon oxide is not particularly limited, and specific examples thereof include the following methods.
First, 2 to 50% by weight of a water-soluble silicate as SiO 2 is added to an aqueous suspension of raw material zinc oxide particles as a total amount of zinc oxide and SiO 2 . Next, while maintaining the temperature at 60 ° C. or higher, acid was added as a neutralizing agent over a period of 40 minutes or more, and the suspension was neutralized until the pH was in the range of 6.0 to 8.0. Thus, the zinc oxide particles can be obtained by forming a high-density coating layer made of silicon oxide on the surfaces of the zinc oxide particles.
上述した製造方法において、水性懸濁液における原料酸化亜鉛粒子の濃度は、50〜250g/Lの範囲が好ましく、また、原料酸化亜鉛粒子は、サンドミル等の粉砕機によって、十分に粉砕しておくことが望ましい。上記水溶性ケイ酸塩としては、ケイ酸ナトリウム又はケイ酸カリウムが好ましく用いられるが、しかし、これらに限定されるものではない。上記中和剤としては、限定されるものではないが、硫酸等の無機酸や、酢酸、シュウ酸等の有機酸が好ましく用いられる。 In the production method described above, the concentration of the raw material zinc oxide particles in the aqueous suspension is preferably in the range of 50 to 250 g / L, and the raw material zinc oxide particles are sufficiently pulverized by a pulverizer such as a sand mill. It is desirable. As the water-soluble silicate, sodium silicate or potassium silicate is preferably used, but is not limited thereto. The neutralizing agent is not limited, but inorganic acids such as sulfuric acid and organic acids such as acetic acid and oxalic acid are preferably used.
更に、上述した製造方法においては、原料酸化亜鉛粒子の水性懸濁液に水溶性ケイ酸塩を加えた後、これに中和剤として酸を加えて、水溶性ケイ酸塩を中和する際の温度条件と中和剤を加える時間条件(時間幅)が重要である。即ち、本発明によれば、酸化亜鉛粒子の水性懸濁液に水溶性ケイ酸塩を加え、この懸濁液の温度を60℃以上、好ましくは、80℃以上に保持しながら、40分以上、好ましくは、60分以上の時間をかけて、中和剤を加え、pHが6.0〜8.0の範囲まで、懸濁液を中和することによって、含水ケイ素酸化物からなる高密度の被覆層を酸化亜鉛粒子の表面に形成することができる。 Furthermore, in the production method described above, after adding a water-soluble silicate to an aqueous suspension of raw material zinc oxide particles, an acid is added thereto as a neutralizing agent to neutralize the water-soluble silicate. The temperature condition and the time condition (time width) for adding the neutralizing agent are important. That is, according to the present invention, a water-soluble silicate is added to an aqueous suspension of zinc oxide particles, and the temperature of the suspension is kept at 60 ° C. or higher, preferably 80 ° C. or higher for 40 minutes or longer. Preferably, a high density of hydrous silicon oxide is obtained by adding a neutralizing agent over a period of 60 minutes or more and neutralizing the suspension to a pH of 6.0 to 8.0. The coating layer can be formed on the surface of the zinc oxide particles.
別の製造方法として、酸化亜鉛粒子の水性懸濁液に、その温度を60℃以上、好ましくは、80℃以上に保持しながら、水溶性ケイ酸塩と中和剤とを、40分以上、好ましくは、60分以上の時間をかけて、同時に加えた後、更に、中和剤を加えて、pHが6.0〜8.0の範囲まで、懸濁液を中和することによっても、含水ケイ素酸化物からなる高密度の被覆層を酸化亜鉛粒子の表面に形成することができる。 As another production method, an aqueous suspension of zinc oxide particles is maintained at a temperature of 60 ° C. or higher, preferably 80 ° C. or higher. Preferably, it is also possible to neutralize the suspension to a pH of 6.0 to 8.0 by adding a neutralizing agent after adding simultaneously over 60 minutes or more. A high-density coating layer made of hydrous silicon oxide can be formed on the surface of the zinc oxide particles.
上記酸化亜鉛粒子においては、ケイ素酸化物からなる被覆層を形成する前に、酸化亜鉛に、上記被覆層の形成を妨げない範囲で、Ti、Zr、Snや、その他の含水酸化物又は酸化物を少量、含有させてもよい。 In the zinc oxide particles, before forming the coating layer made of silicon oxide, Ti, Zr, Sn, and other hydrated oxides or oxides are added to the zinc oxide as long as the formation of the coating layer is not hindered. May be contained in a small amount.
更に、酸化亜鉛の表面にケイ素酸化物からなる被覆層を形成した後、その上に酸化亜鉛に対して0.5〜30重量%、好ましくは、2〜15重量%の範囲のAl、Ti、Zr、Sn、Sb及び希土類元素よりなる群から選ばれる少なくとも1種の酸化物からなる第2の被覆層を形成してもよい。上記希土類元素としては、特に限定されるものではないが、例えば、イットリウム、ランタン、セリウム、ネオジム等を挙げることができる。上記第2の被覆層としては、アルミニウムの酸化物からなるものであることが特に好ましい。 Furthermore, after forming a coating layer made of silicon oxide on the surface of zinc oxide, 0.5-30% by weight, preferably 2-15% by weight of Al, Ti, You may form the 2nd coating layer which consists of at least 1 sort (s) of oxide chosen from the group which consists of Zr, Sn, Sb, and rare earth elements. The rare earth element is not particularly limited, and examples thereof include yttrium, lanthanum, cerium, and neodymium. The second coating layer is particularly preferably made of an oxide of aluminum.
このような第2の被覆層を有する酸化亜鉛粒子は、ケイ素酸化物からなる被覆層を有する酸化亜鉛粒子の水性懸濁液を調製し、これに上記元素の水溶性化合物の水溶液を加え、酸又はアルカリを中和剤として加えて、上記元素の化合物を中和して、上記酸化亜鉛粒子の表面に上記元素の酸化物からなる被覆層を形成することによって得ることができる。 For the zinc oxide particles having such a second coating layer, an aqueous suspension of zinc oxide particles having a coating layer made of silicon oxide is prepared, and an aqueous solution of a water-soluble compound of the above element is added to the zinc oxide particles. Or it can obtain by adding an alkali as a neutralizing agent, neutralizing the compound of the said element, and forming the coating layer which consists of an oxide of the said element on the surface of the said zinc oxide particle.
Alの水溶性化合物としては、例えば、硝酸アルミニウム、硫酸アルミニウム、アルミン酸ナトリウム等を、Tiの水溶性化合物としては、例えば、チタニル硫酸等を、Zrの水溶性化合物としては、例えば、硝酸ジルコニウム、硫酸ジルコニウム等を、Snの水溶性化合物としては、例えば、塩化スズを、Sbの水溶性化合物としては、例えば、塩化アンチモン等を、また、希土類元素の水溶性化合物としては、例えば、硝酸セリウム等を挙げることができる。 Examples of water-soluble compounds of Al include, for example, aluminum nitrate, aluminum sulfate, sodium aluminate, etc., examples of water-soluble compounds of Ti, such as titanyl sulfate, and examples of water-soluble compounds of Zr include, for example, zirconium nitrate, Zirconium sulfate or the like, Sn as a water-soluble compound, for example, tin chloride, Sb as a water-soluble compound, for example, antimony chloride, and the like, and rare earth elements as a water-soluble compound, for example, cerium nitrate, etc. Can be mentioned.
上記中和剤である酸としては、前述したものと同じく、硫酸等の無機酸や、酢酸、シュウ酸等の有機酸が好ましく用いられる。他方、上記中和剤であるアルカリとしては、例えば、水酸化ナトリウム、水酸化カリウム、水酸化アンモニウム等が好ましく用いられる。 As the acid as the neutralizing agent, an inorganic acid such as sulfuric acid and an organic acid such as acetic acid and oxalic acid are preferably used as described above. On the other hand, as the alkali as the neutralizing agent, for example, sodium hydroxide, potassium hydroxide, ammonium hydroxide and the like are preferably used.
ケイ素酸化物からなる第1の被覆層を有する酸化亜鉛粒子組成物に上記元素の酸化物からなる第2の被覆層を形成するに際して、2種以上の元素の酸化物からなる被覆層を形成する場合、複数の元素の水溶性化合物の水溶液を用いて、一度に複数の元素の酸化物の混合物からなる被覆層を形成してもよいが、しかし、個々の元素の水溶性化合物の水溶液を用いて、一層ずつ、酸化物からなる被覆層を形成して、第2の被覆層を多層とするのが好ましい。アルミニウム酸化物を含む複数の元素の酸化物からなる被覆層を形成する場合には、アルミニウム酸化物からなる被覆層を最後に形成することが好ましい。 When forming a second coating layer made of an oxide of the above element on a zinc oxide particle composition having a first coating layer made of silicon oxide, a coating layer made of an oxide of two or more elements is formed. In some cases, an aqueous solution of a water-soluble compound of a plurality of elements may be used to form a coating layer composed of a mixture of oxides of a plurality of elements at a time. Thus, it is preferable to form a coating layer made of an oxide layer by layer, and to make the second coating layer into a multilayer. In the case of forming a coating layer made of oxides of a plurality of elements including aluminum oxide, it is preferable to form the coating layer made of aluminum oxide last.
本発明において使用する酸化亜鉛粒子は、酸化亜鉛粒子の表面にケイ素酸化物からなる被覆層を形成した後又は上記第2の被覆層を形成した後、酸化亜鉛粒子をシリコーン処理したものである。上記シリコーン処理は、アルキルシラン又はオルガノポリシロキサンで処理することが好ましい。 The zinc oxide particles used in the present invention are those obtained by silicone-treating zinc oxide particles after forming a coating layer made of silicon oxide on the surface of the zinc oxide particles or after forming the second coating layer. The silicone treatment is preferably treated with alkylsilane or organopolysiloxane.
上記アルキルシラン又はオルガノポリシロキサンとしては特に限定されず、例えば、トリエトキシカプリリルシラン、メチルハイドロジェンポリシロキサン、トリエトキシシリルエチルポリジメチルシロキシエチルジメチコン(信越化学工業社製KF−9908)、(アクリレーツ/アクリル酸トリデシル/メタクリル酸トリエトキシシリルプロピル/メタクリルジメチコン)コポリマー(信越化学工業社製KP−574)、ジメチルポリシロキサン・メチルハイドロジェンポリシロキサン共重合体、トリエトキシシリルエチルポリジメチルシロキシエチルヘキシルジメチコン(信越化学工業社製KF−9909)、ジメチルポリシロキサン等を挙げることができる。なかでも、ジメチルポリシロキサン・メチルハイドロジェンポリシロキサン共重合体、トリエトキシシリルエチルポリジメチルシロキシエチルジメチコン(KF−9908)及びトリエトキシシリルエチルポリジメチルシロキシエチルヘキシルジメチコン(信越化学工業社製KF−9909)のうち少なくとも一種を使用することが好ましい。これらの化合物から、2種以上を組み合わせて使用するものであってもよい。 The alkylsilane or organopolysiloxane is not particularly limited, and examples thereof include triethoxycaprylylsilane, methylhydrogenpolysiloxane, triethoxysilylethylpolydimethylsiloxyethyl dimethicone (KF-9908 manufactured by Shin-Etsu Chemical Co., Ltd.), / Tridecyl acrylate / triethoxysilylpropyl methacrylate / methacrylic dimethicone) copolymer (KP-574 manufactured by Shin-Etsu Chemical Co., Ltd.), dimethylpolysiloxane / methylhydrogenpolysiloxane copolymer, triethoxysilylethylpolydimethylsiloxyethylhexyl dimethicone ( Examples thereof include KF-9909) manufactured by Shin-Etsu Chemical Co., Ltd. and dimethylpolysiloxane. Among them, dimethylpolysiloxane / methylhydrogenpolysiloxane copolymer, triethoxysilylethyl polydimethylsiloxyethyl dimethicone (KF-9908) and triethoxysilylethyl polydimethylsiloxyethylhexyl dimethicone (KF-9909 manufactured by Shin-Etsu Chemical Co., Ltd.) It is preferable to use at least one of them. Two or more of these compounds may be used in combination.
上記アルキルシラン又はオルガノポリシロキサンによる処理方法としては特に限定されず、例えば、被覆酸化亜鉛粒子をイソプロピルアルコール等の溶媒に分散させた後、上記アルキルシラン又はオルガノポリシロキサンを添加する方法や、乾式でミキサーで混合する方法などを挙げることができる。 The treatment method using the alkylsilane or organopolysiloxane is not particularly limited. For example, after the coated zinc oxide particles are dispersed in a solvent such as isopropyl alcohol, the alkylsilane or organopolysiloxane may be added or dry. The method of mixing with a mixer can be mentioned.
上記表面処理に用いるアルキルシラン又はオルガノポリシロキサンは、当該化合物による処理後の酸化亜鉛粒子に対して、1〜20重量%の範囲であることが好ましく、3〜10重量%の範囲であることがより好ましい。アルキルシラン又はオルガノポリシロキサンが酸化亜鉛に対して1重量%よりも少ないときは、化粧料中の油剤への分散性が不充分となる場合があり、他方、20重量%を越えても、化粧料中の油剤への分散性や撥水性が飽和するので、経済的にも不利となる場合がある。 The alkylsilane or organopolysiloxane used for the surface treatment is preferably in the range of 1 to 20% by weight, preferably in the range of 3 to 10% by weight, based on the zinc oxide particles after the treatment with the compound. More preferred. When the alkylsilane or the organopolysiloxane is less than 1% by weight based on zinc oxide, the dispersibility in the oil in the cosmetic may be insufficient. Since the dispersibility of the oil in the oil and the water repellency are saturated, it may be economically disadvantageous.
本発明において使用する上述したような処理を施した酸化亜鉛粒子は、高い透明性を有するように、原体として平均一次粒子径が0.15μm以下である酸化亜鉛を使用することが好ましい。酸化亜鉛粒子の平均一次粒子径が0.15μmより大きいときは、隠蔽力が大きく、白くなり、透明性が低い。また、紫外線遮蔽効果も低くなってしまう。酸化亜鉛粒子の平均一次粒子径の下限は、特に、限定されるものではないが、通常、0.01μmである。ここに、平均一次粒子径とは、透過型電子顕微鏡写真の10万倍の視野で一定方向径で定義されるものである。 It is preferable to use zinc oxide having an average primary particle diameter of 0.15 μm or less as a raw material so that the zinc oxide particles subjected to the above-described treatment used in the present invention have high transparency. When the average primary particle diameter of the zinc oxide particles is larger than 0.15 μm, the hiding power is large, whitening, and transparency is low. Moreover, the ultraviolet shielding effect is also lowered. The lower limit of the average primary particle diameter of the zinc oxide particles is not particularly limited, but is usually 0.01 μm. Here, the average primary particle diameter is defined by a constant direction diameter in a field of view of 100,000 times that of a transmission electron micrograph.
本発明の酸化亜鉛分散体は、上述したような処理を行った酸化亜鉛粒子を液状シリコーン中に分散させたものである。本発明において使用される液状シリコーンは、常温で液体の性状を有するシリコーン化合物であれば特に限定されるものではないが、なかでも、環状シリコーン化合物であることが好ましい。環状でない液状シリコーンの例としては、直鎖状ジメチルポリシロキサン、トリシロキサン、テトラシロキサン、メチルトリメチコン(信越化学工業社製TMF−1.5)、カプリリルメチコン(東レ・ダウコーニング社製FZ−3196、SS−3408)等を挙げることができる。 The zinc oxide dispersion of the present invention is obtained by dispersing zinc oxide particles that have been treated as described above in liquid silicone. The liquid silicone used in the present invention is not particularly limited as long as it is a silicone compound having liquid properties at room temperature, but among them, a cyclic silicone compound is preferable. Examples of liquid silicones that are not cyclic include linear dimethylpolysiloxane, trisiloxane, tetrasiloxane, methyltrimethicone (TMF-1.5 manufactured by Shin-Etsu Chemical Co., Ltd.), caprylyl methicone (FZ- manufactured by Toray Dow Corning Co., Ltd.). 3196, SS-3408) and the like.
上記環状シリコーン化合物は、メチルシクロポリシロキサンで繰り返し単位が3〜6であるものが好適である。なかでも、繰り返し単位が5である、デカメチルシクロペンタシロキサンが特に好適である。環状シリコーンの配合量は用途や環状シリコーンの種類等によって変化するが、20%〜60%であることが好ましい。 The cyclic silicone compound is preferably methylcyclopolysiloxane having 3 to 6 repeating units. Of these, decamethylcyclopentasiloxane having a repeating unit of 5 is particularly preferred. The blending amount of the cyclic silicone varies depending on the application, the type of the cyclic silicone, and the like, but is preferably 20% to 60%.
本発明の酸化亜鉛分散体に使用する酸化亜鉛は、イソプロパノール(以下、これを「IPA」と記す)に分散させた時のゼータ電位が−90mV以下であることが好ましい。このゼータ電位は粒子の表面電荷が影響を及ぼす限界の部分(すべり面)における電位のことを言い、直接測定することの難しい表面電位の指標となる。 The zinc oxide used in the zinc oxide dispersion of the present invention preferably has a zeta potential of −90 mV or less when dispersed in isopropanol (hereinafter referred to as “IPA”). This zeta potential refers to the potential at the limit part (slip surface) where the surface charge of the particle affects, and is an index of the surface potential that is difficult to measure directly.
本発明の酸化亜鉛分散体において、上記酸化亜鉛粒子は、30〜79.5重量%の割合で含まれることが好ましい。30重量%未満であると、分散媒量が増えるために化粧料に配合する際の処方の自由度が下がってしまう場合がある。79.5重量%を超えると、分散体の粘度が著しく上昇し流動性が失われてしまうおそれがあり、また分散工程の温度管理などが難しくなるおそれがある。 In the zinc oxide dispersion of the present invention, the zinc oxide particles are preferably contained in a proportion of 30 to 79.5% by weight. If it is less than 30% by weight, the amount of the dispersion medium increases, so the degree of freedom of formulation when blended into cosmetics may be reduced. If it exceeds 79.5% by weight, the viscosity of the dispersion may increase significantly and the fluidity may be lost, and the temperature control of the dispersion process may be difficult.
本発明の酸化亜鉛分散体においては、分散剤を使用することが好ましい。これによって、酸化亜鉛粒子を好適に液体媒体中に分散させることができる。分散剤は、特に限定されるものではないが、シリコーン系分散剤を使用すると、良好な分散状態が得られる点で特に好ましい。 In the zinc oxide dispersion of the present invention, it is preferable to use a dispersant. Thereby, the zinc oxide particles can be suitably dispersed in the liquid medium. Although a dispersing agent is not specifically limited, It is especially preferable at the point from which a favorable dispersion state is obtained when a silicone type dispersing agent is used.
上記シリコーン系分散剤としては、ポリオキシアルキレン・アルキル共変性オルガノポリシロキサン(信越化学工業製KF−6038,表示名称:ラウリルPEG−9ポリジメチルシロキシエチルジメチコン)、ポリエチレン変性オルガノポリシロキサン((信越化学工業製KF−6028(KF−6028P);表示名称:PEG−9ポリジメチルシロキシエチルジメチコン)、ポリオキシエチレン・メチルポリシロキサン共重合体、ポリオキシプロピレン・メチルポリシロキサン共重合体、ポリ(オキシエチレン・オキシプロピレン)メチルポリシロキサン共重合体、メチルポリシロキサン・セチルメチルポリシロキサン・ポリ(オキシエチレン・オキシプロピレン)メチルポリシロキサン共重合体、アミノエチルアミノプロピルシロキサン・ジメチルシロキサン共重合体等を挙げることができる。また、ポリオキシエチレンラウリルエーテルリン酸、ポリオキシエチレンステアリルエーテルリン酸、ポリオキシエチレンオレイルエーテルリン酸、ポリオキシエチレンアルキルフェニルエーテルリン酸、ポリオキシエチレンポリオキシプロピレンセチルエーテルリン酸、脂肪酸ポリグリセリン(脂肪酸の炭素数が12〜22で直鎖、分岐を含み、置換脂肪酸数が1〜5で、グリセリンの重合度が2〜10)等の非シリコーン系分散剤も単独又はシリコーン系分散剤と併用して利用できる。 Examples of the silicone dispersant include polyoxyalkylene / alkyl co-modified organopolysiloxane (KF-6038 manufactured by Shin-Etsu Chemical Co., Ltd., display name: lauryl PEG-9 polydimethylsiloxyethyl dimethicone), polyethylene-modified organopolysiloxane ((Shin-Etsu Chemical) Industrial KF-6028 (KF-6028P); display name: PEG-9 polydimethylsiloxyethyl dimethicone), polyoxyethylene / methylpolysiloxane copolymer, polyoxypropylene / methylpolysiloxane copolymer, poly (oxyethylene)・ Oxypropylene) methylpolysiloxane copolymer, methylpolysiloxane, cetylmethylpolysiloxane, poly (oxyethylene, oxypropylene) methylpolysiloxane copolymer, aminoethylaminopropylsiloxy Dimethyl siloxane copolymer, etc. In addition, polyoxyethylene lauryl ether phosphoric acid, polyoxyethylene stearyl ether phosphoric acid, polyoxyethylene oleyl ether phosphoric acid, polyoxyethylene alkylphenyl ether phosphoric acid, polyoxyethylene Such as oxyethylene polyoxypropylene cetyl ether phosphate, fatty acid polyglycerin (fatty acid having 12 to 22 carbon atoms, linear, branched, substituted fatty acid number of 1 to 5, and glycerin polymerization degree of 2 to 10) Non-silicone dispersants can be used alone or in combination with silicone dispersants.
上述した以外の分散剤も上記の分散剤と併用できる。分散剤の配合量は分散剤の種類や粉体の量や質、その他配合する原料によって大きく異なるが、酸化亜鉛分散体の重量に対して0.5〜30重量%が好ましい。0.5重量%未満であると高濃度で顔料を含有させることが難しくなったり、分散体の貯蔵安定性が悪くなったりする場合がある。また、30重量%より多いと化粧料配合時の自由度が狭くなったり、化粧料の使用感が悪くなったりする場合がある。 Dispersants other than those described above can be used in combination with the above dispersants. The amount of the dispersing agent varies greatly depending on the type of dispersing agent, the amount and quality of the powder, and other raw materials to be blended, but is preferably 0.5 to 30% by weight based on the weight of the zinc oxide dispersion. If it is less than 0.5% by weight, it may be difficult to contain the pigment at a high concentration, or the storage stability of the dispersion may be deteriorated. On the other hand, if the amount is more than 30% by weight, the degree of freedom in blending the cosmetic may become narrow, or the cosmetic feel may deteriorate.
本発明の酸化亜鉛分散体においては、この他に油剤を必要により配合してもよい。上記油剤は特に限定はないが、例えば、天然動植物油脂(例えば、オリーブ油、ミンク油、ヒマシ油、パーム油、牛脂、月見草油、ヤシ油、ヒマシ油、カカオ油、マカデミアナッツ油等);蝋(例えば、ホホバ油、ミツロウ、ラノリン、カルナウバロウ、キャンデリラロウ等);高級アルコール(例えば、ラウリルアルコール、ステアリルアルコール、セチルアルコール、オレイルアルコール等);高級脂肪酸(例えば、ラウリン酸、パルミチン酸、ステアリン酸、オレイン酸、ベヘニン酸、ラノリン脂肪酸等;高級脂肪族炭化水素例えば、流動パラフィン、固形パラフィン、スクワラン、ワセリン、セレシン、マイクロクリスタリンワックス等);合成エステル油(例えば、ブチルステアレート、ヘキシルラウレート、ジイソプロピルアジペート、ジイソプロピルセバケート、ミリスチン酸オクチルドデシル、イソプロピルミリステート、イソプロピルパルミテートイソプロピルミリステート、セチルイソオクタノエート、ジカプリン酸ネオペンチルグリコール);シリコーン誘導体(例えば、メチルシリコーン、メチルフェニルシリコーン等のシリコーン油)などが例示できる。さらに、油溶性のビタミン、防腐剤、美白剤などを配合することもできる。 In the zinc oxide dispersion of the present invention, an oil agent may be added if necessary. The oil agent is not particularly limited. For example, natural animal and vegetable oils and fats (for example, olive oil, mink oil, castor oil, palm oil, beef tallow, evening primrose oil, coconut oil, castor oil, cacao oil, macadamia nut oil, etc.); wax (for example, Jojoba oil, beeswax, lanolin, carnauba wax, candelilla wax, etc.); higher alcohols (eg, lauryl alcohol, stearyl alcohol, cetyl alcohol, oleyl alcohol, etc.); higher fatty acids (eg, lauric acid, palmitic acid, stearic acid, olein) Acids, behenic acid, lanolin fatty acids, etc .; higher aliphatic hydrocarbons such as liquid paraffin, solid paraffin, squalane, petrolatum, ceresin, microcrystalline wax, etc .; synthetic ester oils (eg, butyl stearate, hexyl laurate, diisopropyl azimuth) , Diisopropyl sebacate, octyldodecyl myristate, isopropyl myristate, isopropyl palmitate isopropyl myristate, cetyl isooctanoate, neopentyl glycol dicaprate); silicone derivatives (eg, silicones such as methyl silicone and methyl phenyl silicone) Oil) and the like. Furthermore, oil-soluble vitamins, preservatives, whitening agents, and the like can be added.
本発明の酸化亜鉛分散体は、上述したような成分を含む均一相からなる液体媒体中に酸化亜鉛等の粉体成分が分散したものであることが好ましい。すなわち、各種化粧料原料と混合して化粧料を調製する材料として使用すべきものであることから、酸化亜鉛、シリコーンオイル、界面活性剤、その他の油剤以外の成分は配合しないことが好ましい。但し、本発明の分散体としての性能を損なわない範囲内においては、微量成分を添加するものであってもよい。 The zinc oxide dispersion of the present invention is preferably one in which a powder component such as zinc oxide is dispersed in a liquid medium composed of a homogeneous phase containing the components as described above. That is, since it should be used as a material for preparing cosmetics by mixing with various cosmetic raw materials, it is preferable not to add components other than zinc oxide, silicone oil, surfactants and other oils. However, a trace component may be added as long as the performance as the dispersion of the present invention is not impaired.
本発明の酸化亜鉛分散体は酸化チタンのシリコーン分散体と併用する際に、増粘しない点で特に有用である。酸化チタンのシリコーン分散体に使用される酸化チタンは、シリカ処理や水酸化アルミニウム処理の内1つ、若しくは両方の無機表面処理が施された上にシリコーン処理を施されたものが一般的に使用されており、本発明の酸化亜鉛分散体はこの酸化チタンのシリコーン分散体に対して、特に有用である。 The zinc oxide dispersion of the present invention is particularly useful in that it does not thicken when used in combination with a titanium oxide silicone dispersion. Titanium oxide used in titanium oxide silicone dispersion is generally used after one or both of silica treatment and aluminum hydroxide treatment, and silicon treatment. Thus, the zinc oxide dispersion of the present invention is particularly useful for the titanium oxide silicone dispersion.
本発明の酸化亜鉛分散体は、酸化亜鉛以外の無機粒子を配合するものであってもよい。併用することができる無機粒子としては特に限定されるものではないが、例えば、酸化チタン等を挙げることができる。 The zinc oxide dispersion of the present invention may contain inorganic particles other than zinc oxide. Although it does not specifically limit as an inorganic particle which can be used together, For example, a titanium oxide etc. can be mentioned.
特に、酸化チタンを酸化亜鉛と併用した場合には、増粘という問題が顕著になりやすいものであることから、酸化チタンと併用したときに、本発明の効果はより顕著なものとなる。紫外線防御用化粧料における紫外線遮蔽剤として酸化亜鉛を使用する場合には、紫外線の遮蔽域が異なる酸化チタン粒子を併用することが多いため、このような場合に特に本発明は有用なものである。 In particular, when titanium oxide is used in combination with zinc oxide, the problem of thickening tends to become prominent. Therefore, the effect of the present invention becomes more remarkable when used in combination with titanium oxide. When zinc oxide is used as an ultraviolet shielding agent in ultraviolet protective cosmetics, titanium oxide particles having different ultraviolet shielding areas are often used in combination, and the present invention is particularly useful in such cases. .
本発明においては、併用して使用する酸化チタン粒子は特に限定されないが、上述したような酸化亜鉛粒子と同様にケイ素酸化物からなる被覆層を設けた酸化チタン粒子;アルミナ及び/又は水酸化アルミニウムからなる層を設けた酸化チタン粒子;第1の被覆層としてケイ素酸化物からなる層を有し、第二の被覆層としてアルミナ及び/又は水酸化アルミニウムからなる層を有する酸化チタン等を挙げることができる。また、シリカ処理やアルミナ及び/又は水酸化アルミニウム処理を行った後、上述したような酸化亜鉛粒子と同様の第2の被覆層を形成するための処理やシリコーン処理を施したものであってもよい。 In the present invention, titanium oxide particles used in combination are not particularly limited, but titanium oxide particles provided with a coating layer made of silicon oxide in the same manner as zinc oxide particles as described above; alumina and / or aluminum hydroxide Titanium oxide particles provided with a layer comprising: titanium oxide having a layer made of silicon oxide as the first coating layer and a layer made of alumina and / or aluminum hydroxide as the second coating layer Can do. Further, after silica treatment, alumina and / or aluminum hydroxide treatment, a treatment for forming the second coating layer similar to the zinc oxide particles as described above or a silicone treatment may be applied. Good.
酸化チタン粒子へのケイ素酸化物からなる層の形成、アルミナ及び/又は水酸化アルミニウムからなる層の形成は、上述した酸化亜鉛粒子へのアルミナ及び/又は水酸化アルミニウム処理と同様の方法によって行うことができる。 Formation of a layer made of silicon oxide on titanium oxide particles and formation of a layer made of alumina and / or aluminum hydroxide should be performed in the same manner as the above-described treatment of alumina and / or aluminum hydroxide on zinc oxide particles. Can do.
上記酸化チタン粒子は、平均一次粒子径が0.1μm以下のものを使用することが好ましい。酸化チタン粒子の粒子径が0.1μmを超えると、隠蔽力が大きく、白くなり、透明性が低い。酸化チタン粒子の平均一次粒子径の下限は、特に、限定されるものではないが、通常、0.01μmである。なお、平均一次粒子径とは、透過型電子顕微鏡写真の10万倍の視野で一定方向径で定義されるものである。また、この平均一次粒子径は紡錘状酸化チタンの場合には短径方向のサイズが当てはまる。 The titanium oxide particles preferably have an average primary particle diameter of 0.1 μm or less. When the particle diameter of the titanium oxide particles exceeds 0.1 μm, the hiding power is large, whitening, and transparency is low. The lower limit of the average primary particle diameter of the titanium oxide particles is not particularly limited, but is usually 0.01 μm. The average primary particle diameter is defined as a constant direction diameter in a field of view of 100,000 times that of a transmission electron micrograph. The average primary particle size is the size in the minor axis direction in the case of spindle-shaped titanium oxide.
酸化チタン等の酸化亜鉛以外の無機粒子を使用する場合、その配合量は、酸化亜鉛の重量に対して10倍量以下であることが好ましい。10倍量を超えると、酸化亜鉛量が少ないために酸化亜鉛の有する機能を充分に発揮することができない場合がある。 When inorganic particles other than zinc oxide such as titanium oxide are used, the blending amount is preferably 10 times or less with respect to the weight of zinc oxide. When the amount exceeds 10 times, the amount of zinc oxide is small, so that the function of zinc oxide may not be fully exhibited.
酸化チタン等の酸化亜鉛以外の無機粒子を使用する場合、酸化亜鉛を含む無機粒子の合計量が酸化亜鉛分散体全量に対して、30〜79.5重量%であることが好ましい。30重量%未満であると、酸化亜鉛量が少ないために酸化亜鉛の有する機能を充分に発揮することができない場合がある。79.5重量%を超えると、分散が困難になるおそれがある。 When using inorganic particles other than zinc oxide such as titanium oxide, the total amount of inorganic particles containing zinc oxide is preferably 30 to 79.5% by weight based on the total amount of zinc oxide dispersion. If it is less than 30% by weight, the function of zinc oxide may not be fully exhibited because the amount of zinc oxide is small. If it exceeds 79.5% by weight, dispersion may be difficult.
本発明の酸化亜鉛分散体は、公知の通常の製造方法によって得ることができる。具体的には、原料を混合し、これらをロールミルやビーズミルを用いて充分に分散混合する方法等によって得ることができる。 The zinc oxide dispersion of the present invention can be obtained by a known ordinary production method. Specifically, it can be obtained by mixing raw materials and sufficiently dispersing and mixing them using a roll mill or bead mill.
本発明の酸化亜鉛分散体は、化粧品を調製する際の基材として使用することができる。このような酸化亜鉛分散体に、必要に応じて化粧品原料を混合することによって、サンスクリーン剤等の紫外線防御用化粧料;ファンデーション等のベースメイク化粧料;口紅等のポイントメイク化粧料等を得ることができる。このようにして得られた化粧料も本発明の一つである。 The zinc oxide dispersion of the present invention can be used as a base material for preparing cosmetics. A cosmetic raw material is mixed with such a zinc oxide dispersion as necessary to obtain an ultraviolet protection cosmetic such as a sunscreen agent; a base makeup cosmetic such as a foundation; a point makeup cosmetic such as a lipstick. be able to. The cosmetic thus obtained is also one aspect of the present invention.
本発明の化粧料は、油性化粧料、水性化粧料、O/W型化粧料、W/O型化粧料の任意の形態とすることができる。なかでも、サンスクリーン剤において特に好適に使用することができる。 The cosmetics of the present invention can be in any form of oily cosmetics, aqueous cosmetics, O / W type cosmetics, and W / O type cosmetics. Especially, it can use especially suitably in a sunscreen agent.
上記化粧料は、化粧品分野において使用することができる任意の水性成分、油性成分を併用するものであってもよい。上記水性成分及び油性成分としては特に限定されず、例えば、油剤、界面活性剤、保湿剤、高級アルコール、金属イオン封鎖剤、天然及び合成高分子、水溶性及び油溶性高分子、紫外線吸収剤、各種抽出液、有機染料等の色剤、防腐剤、酸化防止剤、色素、増粘剤、pH調整剤、香料、冷感剤、制汗剤、殺菌剤、皮膚賦活剤等の成分を含有するものであってもよい。 The cosmetic may be used in combination with any aqueous component or oily component that can be used in the cosmetic field. The aqueous component and the oil component are not particularly limited, and examples thereof include oil agents, surfactants, humectants, higher alcohols, sequestering agents, natural and synthetic polymers, water-soluble and oil-soluble polymers, ultraviolet absorbers, Contains ingredients such as various extracts, colorants such as organic dyes, preservatives, antioxidants, pigments, thickeners, pH adjusters, fragrances, cooling agents, antiperspirants, bactericides, and skin activators. It may be a thing.
上記油剤としては、上述した各種の物を使用することができる。
上記親油性非イオン界面活性剤としては特に限定されず、例えば、ソルビタンモノオレエート、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ソルビタンセスキオレエート、ソルビタントリオレエート、ペンタ−2−エチルヘキシル酸ジグリセロールソルビタン、テトラ−2−エチルヘキシル酸ジグリセロールソルビタン等のソルビタン脂肪酸エステル類、モノ綿実油脂肪酸グリセリン、モノエルカ酸グリセリン、セスキオレイン酸グリセリン、モノステアリン酸グリセリン、α,α’−オレイン酸ピログルタミン酸グリセリン、モノステアリン酸グリセリンリンゴ酸等のグリセリンポリグリセリン脂肪酸類、モノステアリン酸プロピレングリコール等のプロピレングリコール脂肪酸エステル類、硬化ヒマシ油誘導体、グリセリンアルキルエーテル等を挙げることができる。
As said oil agent, the various things mentioned above can be used.
The lipophilic nonionic surfactant is not particularly limited. For example, sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate. Sorbitan fatty acid esters such as diglycerol sorbitan penta-2-ethylhexylate, diglycerol sorbitan tetra-2-ethylhexylate, mono-cotton oil fatty acid glycerin, glyceryl monoerucate, glyceryl sesquioleate, glyceryl monostearate, α, α '-Glycerol polyglycerin fatty acids such as glyceryl oleate pyroglutamate, glyceryl monostearate malate, propylene glycol monostearate It can be exemplified glycol fatty acid esters, hardened castor oil derivatives, glycerin alkyl ether.
親水性非イオン界面活性剤としては特に限定されず、例えば、POEソルビタンモノオレエート、POE−ソルビタンモノステアレート、POE−ソルビタンモノオレエート、POE−ソルビタンテトラオレエート等のPOEソルビタン脂肪酸エステル類、POE−ソルビットモノラウレート、POE−ソルビットモノオレエート、POE−ソルビットペンタオレエート、POE−ソルビットモノステアレート等のPOEソルビット脂肪酸エステル類、POE−グリセリンモノステアレート、POE−グリセリンモノイソステアレート、POE−グリセリントリイソステアレート等のPOEグリセリン脂肪酸エステル類、POEモノオレエート、POEジステアレート、POEモノジオレエート、システアリン酸エチレングリコール等のPOE脂肪酸エステル類、POEラウリルエーテル、POEオレイルエーテル、POEステアリルエーテル、POEベヘニルエーテル、POE2−オクチルドデシルエーテル、POEコレスタノールエーテル等のPOEアルキルエーテル類、POEオクチルフェニルエーテル、POEノニルフェニルエーテル、POEジノニルフェニルエーテル等のPOEアルキルフェニルエーテル類、ブルロニック等のプルアロニック型類、POE・POPセチルエーテル、POE・POP2−デシルテトラデシルエーテル、POE・POPモノブチルエーテル、POE・POP水添ラノリン、POE・POPグリセリンエーテル等のPOE・POPアルキルエーテル類、テトロニック等のテトラPOE・テトラPOPエチレンジアミン縮合物類、POEヒマシ油、POE硬化ヒマシ油、POE硬化ヒマシ油モノイソステアレート、POE硬化ヒマシ油トリイソステアレート、POE硬化ヒマシ油モノピログルタミン酸モノイソステアリン酸ジエステル、POE硬化ヒマシ油マレイン酸等のPOEヒマシ油硬化ヒマシ油誘導体、POEソルビットミツロウ等のPOEミツロウ・ラノリン誘導体、ヤシ油脂肪酸ジエタノールアミド、ラウリン酸モノエタノールアミド、脂肪酸イソプロパノールアミド等のアルカノールアミド、POEプロピレングリコール脂肪酸エステル、POEアルキルアミン、POE 脂肪酸アミド、ショ糖脂肪酸エステル、POE ノニルフェニルホルムアルデヒド縮合物、アルキルエトキシジメチルアミンオキシド、トリオレイルリン酸等を挙げることができる。 The hydrophilic nonionic surfactant is not particularly limited. For example, POE sorbitan fatty acid esters such as POE sorbitan monooleate, POE-sorbitan monostearate, POE-sorbitan monooleate, POE-sorbitan tetraoleate, POE sorbite fatty acid esters such as POE-sorbite monolaurate, POE-sorbite monooleate, POE-sorbite pentaoleate, POE-sorbite monostearate, POE-glycerol monostearate, POE-glycerol monoisostearate, POE glycerol fatty acid esters such as POE-glycerin triisostearate, POE monooleate, POE distearate, POE monodiolate, PO such as ethylene glycol stearate Fatty acid esters, POE lauryl ether, POE oleyl ether, POE stearyl ether, POE behenyl ether, POE2-octyldodecyl ether, POE alkyl ethers such as POE cholestanol ether, POE octylphenyl ether, POE nonylphenyl ether, POE dinonyl POE alkyl phenyl ethers such as phenyl ether, pluronic types such as brulonic, POE / POP cetyl ether, POE / POP2-decyltetradecyl ether, POE / POP monobutyl ether, POE / POP hydrogenated lanolin, POE / POP glycerin ether POE / POP alkyl ethers such as Tetronic, Tetra POE / Tetra POP ethylenediamine condensates such as Tetronic, POE Castor POE hydrogenated castor oil, POE hydrogenated castor oil monoisostearate, POE hydrogenated castor oil triisostearate, POE hydrogenated castor oil monopyroglutamic acid monoisostearic acid diester, POE hydrogenated castor oil maleic acid, etc. Derivatives, POE beeswax / lanolin derivatives such as POE sorbite beeswax, alkanolamides such as coconut oil fatty acid diethanolamide, lauric acid monoethanolamide, fatty acid isopropanolamide, POE propylene glycol fatty acid ester, POE alkylamine, POE fatty acid amide, sucrose fatty acid Examples thereof include esters, POE nonylphenyl formaldehyde condensates, alkylethoxydimethylamine oxide, trioleyl phosphoric acid and the like.
その他の界面活性剤としては、例えば、脂肪酸セッケン、高級アルキル硫酸エステル塩、POEラウリル硫酸トリエタノールアミン、アルキルエーテル硫酸エステル塩等のアニオン界面活性剤、アルキルトリメチルアンモニウム塩、アルキルピリジニウム塩、アルキル四級アンモニウム塩、アルキルジメチルベンジルアンモニウム塩、POEアルキルアミン、アルキルアミン塩、ポリアミン脂肪酸誘導体等のカチオン界面活性剤、及び、イミダゾリン系両性界面活性剤、ベタイン系界面活性剤等の両性界面活性剤を安定性及び皮膚刺激性に問題のない範囲で配合してもよい。 Examples of other surfactants include anionic surfactants such as fatty acid soaps, higher alkyl sulfates, POE lauryl sulfate triethanolamine, alkyl ether sulfates, alkyltrimethylammonium salts, alkylpyridinium salts, alkyl quaternary salts. Stabilizes cationic surfactants such as ammonium salts, alkyldimethylbenzylammonium salts, POE alkylamines, alkylamine salts, polyamine fatty acid derivatives, and amphoteric surfactants such as imidazoline-based amphoteric surfactants and betaine-based surfactants. And you may mix | blend in the range which does not have a problem in skin irritation.
上記保湿剤としては特に限定されず、例えば、キシリトール、ソルビトール、マルチトール、コンドロイチン硫酸、ヒアルロン酸、ムコイチン硫酸、カロニン酸、アテロコラーゲン、コレステリル−12−ヒドロキシステアレート、乳酸ナトリウム、胆汁酸塩、dl−ピロリドンカルボン酸塩、短鎖可溶性コラーゲン、ジグリセリン(EO)PO付加物、イサイヨバラ抽出物、セイヨウノキギリソウ抽出物、メリロート抽出物等を挙げることができる。 The moisturizing agent is not particularly limited, and examples thereof include xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronic acid, atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salt, dl- Examples thereof include pyrrolidone carboxylate, short-chain soluble collagen, diglycerin (EO) PO adduct, Isaiyobara extract, Achillea millefolium extract, and Merirot extract.
上記高級アルコールとしては特に限定されず、例えば、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール等の直鎖アルコール、モノステアリルグリセリンエーテル(バチルアルコール)、2−デシルテトラデシノール、ラノリンアルコール、コレステロール、フィトステロール、ヘキシルドデカノール、イソステアリルアルコール、オクチルドデカノール等の分枝鎖アルコール等を挙げることができる。 The higher alcohol is not particularly limited, and examples thereof include linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, monostearyl glycerin ether (batyl alcohol), 2-decyl. Examples thereof include branched chain alcohols such as tetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, octyldodecanol, and the like.
金属イオン封鎖剤としては特に限定されず、例えば、1−ヒドロキシエタン−1,1− ジフォスホン酸、1−ヒドロキシエタン−1,1−ジフォスホン酸四ナトリウム塩、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸、リン酸、クエン酸、アスコルビン酸、コハク酸、エデト酸等を挙げることができる。 The sequestering agent is not particularly limited. For example, 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, sodium citrate, sodium polyphosphate, metaphosphoric acid Examples thereof include sodium, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, edetic acid and the like.
上記天然の水溶性高分子としては特に限定されず、例えば、アラアビアガム、トラガカントガム、ガラクタン、グアガム、キャロブガム、カラヤガム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)、アルゲコロイド(カッソウエキス)、デンプン(コメ、トウモロコシ、バレイショ、コムギ)、グリチルリチン酸等の植物系高分子、キサンタンガム、デキストラン、サクシノグルカン、プルラン等の微生物系高分子、コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系高分子を挙げることができる。 The natural water-soluble polymer is not particularly limited. For example, arabia gum, tragacanth gum, galactan, guar gum, carob gum, caraya gum, carrageenan, pectin, agar, quince seed (malmello), alge colloid (guckweed extract), starch (rice, rice, Corn, potato, wheat), plant polymers such as glycyrrhizic acid, microbial polymers such as xanthan gum, dextran, succinoglucan and pullulan, and animal polymers such as collagen, casein, albumin and gelatin. .
半合成の水溶性高分子としては特に限定されず、例えば、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子、メチルセルロース、ニトロセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム(CMC)、結晶セルロース、セルロース末等のセルロース系高分子、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高分子等を挙げることができる。 The semi-synthetic water-soluble polymer is not particularly limited. For example, starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch, methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, sodium cellulose sulfate, Examples thereof include cellulose polymers such as hydroxypropylcellulose, sodium carboxymethylcellulose (CMC), crystalline cellulose, and cellulose powder, and alginic acid polymers such as sodium alginate and propylene glycol alginate.
合成の水溶性高分子としては特に限定されず、例えば、ポリビニルアルコール、ポリビニルメチルエーテル、ポリビニルピロリドン等のビニル系高分子、ポリエチレングリコール20,000、40,000、60,000等のポリオキシエチレン系高分子、ポリオキシエチレンポリオキシプロピレン共重合体共重合系高分子、ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等のアクリル系高分子、ポリエチレンイミン、カチオンポリマー等を挙げることができる。 The synthetic water-soluble polymer is not particularly limited, and examples thereof include vinyl polymers such as polyvinyl alcohol, polyvinyl methyl ether, and polyvinyl pyrrolidone, and polyoxyethylene polymers such as polyethylene glycol 20,000, 40,000, and 60,000. Examples thereof include polymers, polyoxyethylene polyoxypropylene copolymer copolymer polymers, acrylic polymers such as sodium polyacrylate, polyethyl acrylate and polyacrylamide, polyethyleneimine, and cationic polymers.
無機の水溶性高分子としては特に限定されず、例えば、ベントナイト、ケイ酸A1Mg(ビーガム)、ラポナイト、ヘクトライト、無水ケイ酸等を挙げることができる。 The inorganic water-soluble polymer is not particularly limited, and examples thereof include bentonite, silicate A1Mg (beegum), laponite, hectorite, and silicic anhydride.
紫外線遮蔽剤としては特に限定されず、例えば、パラアミノ安息香酸(以下PABAと略す)、PABAモノグリセリンエステル、N,N−ジプロポキシPABAエチルエステル、N,N−ジエトキシPABAエチルエステル、N,N−ジメチルPABAエチルエステル、N,N−ジメチルPABAブチルエステル等の安息香酸系紫外線遮蔽剤;ホモメンチル−N−アセチルアントラニレート等のアントラニル酸系紫外線遮蔽剤;アミルサリシレート、メンチルサリシレート、ホモメンチルサリシレート、オクチルサリシレート、フェニルサリシレート、ベンジルサリシレート、p−イソプロパノールフェニルサリシレート等のサリチル酸系紫外線遮蔽剤;オクチルシンナメート、エチル−4−イソプロピルシンナメート、メチル−2,5−ジイソプロピルシンナメート、エチル−2,4−ジイソプロピルシンナメート、メチル−2,4−ジイソプロピルシンナメート、プロピル−p−メトキシシンナメート、イソプロピル−p−メトキシシンナメート、イソアミル−p−メトキシシンナメート、2−エトキシエチル−p−メトキシシンナメート、シクロヘキシル−p−メトキシシンナメート、エチル−α−シアノ−β−フェニルシンナメート、2−エチルヘキシル−α−シアノ−β−フェニルシンナメート、グリセリルモノ−2−エチルヘキサノイル−ジパラメトキシシンナメート等のケイ皮酸系紫外線遮蔽剤;2,4−ジヒドロキシベンゾフェノン、2,2’−ジヒドロキシ−4−メトキシベンゾフェノン、2,2’−ジヒドロキシ−4,4’−ジメトキシベンゾフェノン、2,2’,4,4’−テトラヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシ−4’−メチルベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−フェニルベンゾフェノン、2−エチルヘキシル−4’−フェニル−ベンゾフェノン−2−カルボキシレート、2−ヒドロキシ−4−n−オクトキシベンゾフェノン、4−ヒドロキシ−3− カルボキシベンゾフェノン等のベンゾフェノン系紫外線遮蔽剤;3−(4’−メチルベンジリデン)−d,l−カンファー、3−ベンジリデン−d,l−カンファー、ウロカニン酸、ウロカニン酸エチルエステル、2−フェニル−5− メチルベンゾキサゾール、2,2’−ヒドロキシ−5−メチルフェニルベンゾトリアゾール、2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、2−(2’−ヒドロキシ−5’−メチルフェニルベンゾトリアゾール、ジベンザラジン、ジアニソイルメタン、4−メトキシ−4’−t−ブチルジベンゾイルメタン、5−(3,3−ジメチル−2−ノルボルニリデン)−3−ペンタン−2−オン等を挙げることができる。 The ultraviolet screening agent is not particularly limited. For example, paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester, N, N-dimethyl Benzoic acid UV screening agents such as PABA ethyl ester and N, N-dimethyl PABA butyl ester; Anthranilic acid UV screening agents such as homomenthyl-N-acetylanthranylate; Amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate , Salicylic acid UV screening agents such as phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate; octylcinnamate, ethyl-4-isopropylcinnamate, methyl-2,5- Isopropyl cinnamate, ethyl-2,4-diisopropyl cinnamate, methyl-2,4-diisopropyl cinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, 2- Ethoxyethyl-p-methoxycinnamate, cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate, glyceryl mono-2-ethylhexa Cinnamic acid-based ultraviolet screening agents such as noyl-diparamethoxycinnamate; 2,4-dihydroxybenzophenone, 2,2′-dihydroxy-4-methoxybenzophenone, 2,2′-dihydroxy-4,4′-dimethoxybenzophenone , 2, 2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4 -Benzophenone-based UV shielding agents such as phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxybenzophenone; (4'-methylbenzylidene) -d, l-camphor, 3-benzylidene-d, l-camphor, urocanic acid, urocanic acid ethyl ester, 2-phenyl-5-methylbenzoxazole, 2,2'-hydroxy- 5-methylphenylbenzoto Riazole, 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole, 2- (2′-hydroxy-5′-methylphenylbenzotriazole), dibenzalazine, dianisoylmethane, 4-methoxy-4′- Examples thereof include t-butyldibenzoylmethane and 5- (3,3-dimethyl-2-norbornylidene) -3-pentan-2-one.
その他薬剤成分としては特に限定されず、例えば、ビタミンA油、レチノール、パルミチン酸レチノール、イノシット、塩酸ピリドキシン、ニコチン酸ベンジル、ニコチン酸アミド、ニコチン酸DL−α−トコフェロール、アルコルビン酸リン酸マグネシウム、2−O−α−D−グルコピラノシル−L−アスコルビン酸、ビタミンD2(エルゴカシフェロール)、dl−α−トコフェロール、酢酸dl−α−トコフェロール、パントテン酸、ビオチン等のビタミン類;エストラジオール、エチニルエストラジオール等のホルモン;アルギニン、アスパラギン酸、シスチン、システイン、メチオニン、セリン、ロイシン、トリプトファン等のアミノ酸;アラントイン、アズレン等の抗炎症剤、アルブチン等の美白剤、;タンニン酸等の収斂剤;L−メントール、カンフル等の清涼剤やイオウ、塩化リゾチーム、塩化ピリドキシン等を挙げることができる。 Other drug components are not particularly limited and include, for example, vitamin A oil, retinol, retinol palmitate, inosit, pyridoxine hydrochloride, benzyl nicotinate, nicotinamide, nicotinic acid DL-α-tocopherol, magnesium ascorbate phosphate, 2 Vitamins such as -O-α-D-glucopyranosyl-L-ascorbic acid, vitamin D2 (ergocaciferol), dl-α-tocopherol, dl-α-tocopherol acetate, pantothenic acid, biotin; estradiol, ethinylestradiol, etc. Hormones; amino acids such as arginine, aspartic acid, cystine, cysteine, methionine, serine, leucine and tryptophan; anti-inflammatory agents such as allantoin and azulene; whitening agents such as arbutin; astringents such as tannic acid; L Menthol, cooling agents and sulfur camphor such as, lysozyme chloride, can be mentioned pyridoxine chloride, and the like.
各種の抽出液としては特に限定されず、例えば、ドクダミエキス、オウバクエキス、メリロートエキス、オドリコソウエキス、カンゾウエキス、シャクヤクエキス、サボンソウエキス、ヘチマエキス、キナエキス、ユキノシタエキス、クララエキス、コウホネエキス、ウイキョウエキス、サクラソウエキス、バラエキス、ジオウエキス、レモンエキス、シコンエキス、アロエエキス、ショウブ根エキス、ユーカリエキス、スギナエキス、セージエキス、タイムエキス、茶エキス、海藻エキス、キューカンバーエキス、チョウジエキス、キイチゴエキス、メリッサエキス、ニンジンエキス、マロニエエキス、モモエキス、桃葉エキス、クワエキス、ヤグリマギクエキス、ハマメリスエキス、プラセンタエキス、胸腺抽出物、シルク抽出液、甘草エキス等を挙げることができる There are no particular limitations on the various extracts, for example, Dokudami extract, Oat extract, Merirot extract, Odorikosou extract, Licorice extract, Peonies extract, Soap extract, Loofah extract, Kina extract, Yukinoshita extract, Clara extract, Kouhone extract, Fennel Extract, Primrose Extract, Rose Extract, Giant Extract, Lemon Extract, Shikon Extract, Aloe Extract, Shobu Root Extract, Eucalyptus Extract, Horsetail Extract, Sage Extract, Thyme Extract, Tea Extract, Seaweed Extract, Cucumber Extract, Clove Extract, Raspberry Extract, Melissa Extract , Carrot extract, horse chestnut extract, peach extract, peach leaf extract, mulberry extract, cornflower extract, hamamelis extract, placenta extract, thymus extract, silk extract, licorice Mention may be made of a kiss, etc.
上記各種粉体としては、ベンガラ、黄酸化鉄、黒酸化鉄、雲母チタン、酸化鉄被覆雲母チタン、酸化チタン被覆ガラスフレーク等の光輝性着色顔料、マイカ、タルク、カオリン、セリサイト、二酸化チタン、シリカ等の無機粉末やポリエチレン末、ナイロン末、架橋ポリスチレン、セルロースパウダー、シリコーン末等の有機粉末等を挙げることができる。好ましくは、官能特性向上、化粧持続性向上のため、粉末成分の一部又は全部をシリコーン類、フッ素化合物、金属石鹸、油剤、アシルグルタミン酸塩等の物質にて、公知の方法で疎水化処理して使用される。また、本発明に該当しない他の酸化亜鉛粒子を混合して使用するものであてもよい。 Examples of the various powders include bengara, yellow iron oxide, black iron oxide, titanium mica, iron oxide-coated mica titanium, titanium oxide-coated glass flakes and other bright colored pigments, mica, talc, kaolin, sericite, titanium dioxide, Examples thereof include inorganic powders such as silica and organic powders such as polyethylene powder, nylon powder, crosslinked polystyrene, cellulose powder, and silicone powder. Preferably, a part or all of the powder component is hydrophobized by a known method with a substance such as silicones, fluorine compounds, metal soaps, oils, acyl glutamates in order to improve sensory characteristics and cosmetic durability. Used. Moreover, you may mix and use the other zinc oxide particle which does not correspond to this invention.
以下に実施例を挙げて本発明を説明するが、本発明はこれらの実施例によって何ら限定されるものではない。また実施例中、「部」は特に断りのない限り「重量部」を、「%」は特に断りのない限り「重量%」を意味する。 EXAMPLES The present invention will be described below with reference to examples, but the present invention is not limited to these examples. In the examples, “part” means “part by weight” unless otherwise specified, and “%” means “% by weight” unless otherwise specified.
ゼータ電位の測定方法
粒子をIPAに10重量%となるように投入し、超音波ホモジナイザーにて3分間分散した。この作製したサンプルを用い、粒度分布・ゼータ電位測定装置DT−1200(Dispersion technology社製)を用いてゼータ電位を測定した。計8回測定し、平均値をその粒子のゼータ電位とした。
Measuring method of zeta potential Particles were put into IPA so as to be 10% by weight, and dispersed with an ultrasonic homogenizer for 3 minutes. Using this prepared sample, the zeta potential was measured using a particle size distribution / zeta potential measuring device DT-1200 (manufactured by Dispersion technology). A total of 8 measurements were taken, and the average value was taken as the zeta potential of the particles.
実施例1
表面にシリカ層を形成した酸化亜鉛粒子に対してジメチルポリシロキサン・メチルハイドロジェンポリシロキサン共重合体処理を施すことによって得られた粒子を作製した。なお、表面処理前の原料酸化亜鉛粒子の比表面積(BET法)は、50m2/g、処理前の粒子の平均一次粒子径は0.02μmであり、シリカ層は処理後の粒子全量に対して10重量%、シリコーン層は処理後の粒子全量に対して4重量%であった。その粒子のIPA中でのゼータ電位は−104mVであった。
得られた酸化亜鉛50部、デカメチルシクロペンタシロキサン(KF−995、信越化学工業社製)6部、ポリエーテル変性シリコーン(KF−6038、信越化学工業社製)及びφ0.5mmジルコニアビーズ100部をマヨネーズ瓶に入れ、混合した後、ペイントシェーカー(レッドデビル社製)で1時間処理した。ビーズを分離することで酸化亜鉛分散体を得た。
Example 1
Particles obtained by applying dimethylpolysiloxane / methylhydrogenpolysiloxane copolymer treatment to zinc oxide particles having a silica layer formed on the surface were prepared. In addition, the specific surface area (BET method) of the raw material zinc oxide particles before the surface treatment is 50 m 2 / g, the average primary particle diameter of the particles before the treatment is 0.02 μm, and the silica layer is based on the total amount of the particles after the treatment. 10% by weight, and the silicone layer was 4% by weight based on the total amount of particles after treatment. The zeta potential of the particles in IPA was −104 mV.
50 parts of the obtained zinc oxide, 6 parts of decamethylcyclopentasiloxane (KF-995, manufactured by Shin-Etsu Chemical Co., Ltd.), polyether-modified silicone (KF-6038, manufactured by Shin-Etsu Chemical Co., Ltd.) and 100 parts of φ0.5 mm zirconia beads Was put into a mayonnaise bottle, mixed, and then treated with a paint shaker (manufactured by Red Devil) for 1 hour. A zinc oxide dispersion was obtained by separating the beads.
実施例2
表面にシリカ層を形成した酸化亜鉛粒子に対してジメチルポリシロキサン・メチルハイドロジェンポリシロキサン共重合体処理を施すことによって得られた粒子を作製した。なお、表面処理前の原料酸化亜鉛粒子の比表面積(BET法)は、50m2/g、処理前の粒子の平均一次粒子径は0.02μmであり、シリカ層は処理後の粒子全量に対して20重量%、シリコーン層は処理後の粒子全量に対して4重量%であった。その粒子のIPA中でのゼータ電位は−119mVであった。得られた酸化亜鉛50部、デカメチルシクロペンタシロキサン(KF−995、信越化学工業社製)6部、ポリエーテル変性シリコーン(KF−6038、信越化学工業社製)及びφ0.5mmジルコニアビーズ100部をマヨネーズ瓶に入れ、混合した後、ペイントシェーカー(レッドデビル社製)で1時間処理した。ビーズを分離することで酸化亜鉛分散体を得た。
Example 2
Particles obtained by applying dimethylpolysiloxane / methylhydrogenpolysiloxane copolymer treatment to zinc oxide particles having a silica layer formed on the surface were prepared. In addition, the specific surface area (BET method) of the raw material zinc oxide particles before the surface treatment is 50 m 2 / g, the average primary particle diameter of the particles before the treatment is 0.02 μm, and the silica layer is based on the total amount of the particles after the treatment. The amount of the silicone layer was 4% by weight based on the total amount of the particles after the treatment. The zeta potential of the particles in IPA was −119 mV. 50 parts of the obtained zinc oxide, 6 parts of decamethylcyclopentasiloxane (KF-995, manufactured by Shin-Etsu Chemical Co., Ltd.), polyether-modified silicone (KF-6038, manufactured by Shin-Etsu Chemical Co., Ltd.) and 100 parts of φ0.5 mm zirconia beads Was put into a mayonnaise bottle, mixed, and then treated with a paint shaker (manufactured by Red Devil) for 1 hour. A zinc oxide dispersion was obtained by separating the beads.
実施例3
表面にシリカ層を形成した酸化亜鉛粒子に対してジメチルポリシロキサン・メチルハイドロジェンポリシロキサン共重合体処理を施すことによって得られた粒子を作製した。なお、表面処理前の原料酸化亜鉛粒子の比表面積(BET法)は、30m2/g、処理前の粒子の平均一次粒子径は0.035μmであり、シリカ層は処理後の粒子全量に対して5重量%、シリコーン層は処理後の粒子全量に対して4重量%であった。その粒子のIPA中でのゼータ電位は−133mVであった。得られた酸化亜鉛50部、デカメチルシクロペンタシロキサン(KF−995、信越化学工業社製)6部、ポリエーテル変性シリコーン(KF−6038、信越化学工業社製)及びφ0.5mmジルコニアビーズ100部をマヨネーズ瓶に入れ、混合した後、ペイントシェーカー(レッドデビル社製)で1時間処理した。ビーズを分離することで酸化亜鉛分散体を得た。
Example 3
Particles obtained by applying dimethylpolysiloxane / methylhydrogenpolysiloxane copolymer treatment to zinc oxide particles having a silica layer formed on the surface were prepared. The specific surface area (BET method) of the raw material zinc oxide particles before the surface treatment is 30 m 2 / g, the average primary particle diameter of the particles before the treatment is 0.035 μm, and the silica layer is based on the total amount of the particles after the treatment. 5% by weight, and the silicone layer was 4% by weight with respect to the total amount of particles after treatment. The zeta potential of the particles in IPA was -133 mV. 50 parts of the obtained zinc oxide, 6 parts of decamethylcyclopentasiloxane (KF-995, manufactured by Shin-Etsu Chemical Co., Ltd.), polyether-modified silicone (KF-6038, manufactured by Shin-Etsu Chemical Co., Ltd.) and 100 parts of φ0.5 mm zirconia beads Was put into a mayonnaise bottle, mixed, and then treated with a paint shaker (manufactured by Red Devil) for 1 hour. A zinc oxide dispersion was obtained by separating the beads.
比較例1
表面にシリカ層を形成しない酸化亜鉛粒子に対してジメチルポリシロキサン・メチルハイドロジェンポリシロキサン共重合体処理を施すことによって得られた粒子を作製した。なお、表面処理前の原料酸化亜鉛粒子の比表面積(BET法)は、50m2/g、処理前の粒子の平均一次粒子径は0.02μmであり、シリコーン層は処理後の粒子全量に対して4重量%であった。その粒子のIPA中でのゼータ電位は−18mVであった。得られた酸化亜鉛50部、デカメチルシクロペンタシロキサン(KF−995、信越化学工業社製)6部、ポリエーテル変性シリコーン(KF−6038、信越化学工業社製)及びφ0.5mmジルコニアビーズ100部をマヨネーズ瓶に入れ、混合した後、ペイントシェーカー(レッドデビル社製)で1時間処理した。ビーズを分離することで酸化亜鉛分散体を得た。
Comparative Example 1
Particles obtained by subjecting zinc oxide particles not forming a silica layer on the surface to dimethylpolysiloxane / methylhydrogenpolysiloxane copolymer treatment were prepared. In addition, the specific surface area (BET method) of the raw material zinc oxide particles before the surface treatment is 50 m 2 / g, the average primary particle diameter of the particles before the treatment is 0.02 μm, and the silicone layer is based on the total amount of the particles after the treatment. 4% by weight. The particle had a zeta potential in IPA of -18 mV. 50 parts of the obtained zinc oxide, 6 parts of decamethylcyclopentasiloxane (KF-995, manufactured by Shin-Etsu Chemical Co., Ltd.), polyether-modified silicone (KF-6038, manufactured by Shin-Etsu Chemical Co., Ltd.) and 100 parts of φ0.5 mm zirconia beads Was put into a mayonnaise bottle, mixed, and then treated with a paint shaker (manufactured by Red Devil) for 1 hour. A zinc oxide dispersion was obtained by separating the beads.
比較例2
表面にシリカ層を形成した酸化亜鉛粒子に対してジメチルポリシロキサン・メチルハイドロジェンポリシロキサン共重合体処理を施すことによって得られた粒子を作製した。なお、表面処理前の原料酸化亜鉛粒子の比表面積(BET法)は、50m2/g、処理前の粒子の平均一次粒子径は0.02μmであり、シリカ層は処理後の粒子全量に対して1重量%、シリコーン層は処理後の粒子全量に対して4重量%であった。その粒子のIPA中でのゼータ電位は−44mVであった。
得られた酸化亜鉛50部、デカメチルシクロペンタシロキサン(KF−995、信越化学工業社製)6部、ポリエーテル変性シリコーン(KF−6038、信越化学工業社製)及びφ0.5mmジルコニアビーズ100部をマヨネーズ瓶に入れ、混合した後、ペイントシェーカー(レッドデビル社製)で1時間処理した。ビーズを分離することで酸化亜鉛分散体を得た。
Comparative Example 2
Particles obtained by applying dimethylpolysiloxane / methylhydrogenpolysiloxane copolymer treatment to zinc oxide particles having a silica layer formed on the surface were prepared. In addition, the specific surface area (BET method) of the raw material zinc oxide particles before the surface treatment is 50 m 2 / g, the average primary particle diameter of the particles before the treatment is 0.02 μm, and the silica layer is based on the total amount of the particles after the treatment. The amount of the silicone layer was 4% by weight based on the total amount of the particles after the treatment. The zeta potential of the particles in IPA was -44 mV.
50 parts of the obtained zinc oxide, 6 parts of decamethylcyclopentasiloxane (KF-995, manufactured by Shin-Etsu Chemical Co., Ltd.), polyether-modified silicone (KF-6038, manufactured by Shin-Etsu Chemical Co., Ltd.) and 100 parts of φ0.5 mm zirconia beads Was put into a mayonnaise bottle, mixed, and then treated with a paint shaker (manufactured by Red Devil) for 1 hour. A zinc oxide dispersion was obtained by separating the beads.
[粘度]
50mlのスクリュー瓶に酸化亜鉛分散体を入れ、B型粘度計(東京計器社製)でローターNo.3を使用し、回転開始から60秒後の粘度を測定した。分散後の粘度(20℃)のデータを表1に示す。
[viscosity]
Place the zinc oxide dispersion in a 50 ml screw bottle and use a B-type viscometer (manufactured by Tokyo Keiki Co., Ltd.) to set the rotor 3 was used, and the viscosity 60 seconds after the start of rotation was measured. Table 1 shows the data of the viscosity after dispersion (20 ° C.).
[酸化チタンとの混合試験]
疎水化処理酸化チタン(STR−100A−LP、堺化学工業社製)40部、デカメチルシクロペンタシロキサン(KF−995、信越化学工業社製)6部、ポリエーテル変性シリコーン(KF−6038、信越化学工業社製)及びφ0.5mmジルコニアビーズ100部をマヨネーズ瓶に入れ、混合した後、ペイントシェーカー(レッドデビル社製)で1時間処理した。ビーズを分離することで酸化チタン分散体を得た。なお、表面処理前の原料酸化チタン粒子の比表面積(BET法)は、100m2/gの紡錘状(平均一次粒子径は短径が0.02μm、長径が0.1μm)であり、シリカ層は処理後の粒子全量に対して重量8%、水酸化アルミニウム層は処理後の粒子全量に対して4重量%、シリコーン層は処理後の粒子全量に対して4重量%であった。50mlのスクリュー瓶に実施例1〜3及び比較例1、2で作製した酸化亜鉛分散体を各々30g入れ、そこに得られた酸化チタン分散体を各々30g添加した。その後、100回上下に振り混ぜ酸化亜鉛分散体と酸化チタン分散体の混合物を得た。酸化チタン分散体及び混合物をB型粘度計(東京計器社製)でローターNo.3を使用し、回転開始から60秒後の粘度を測定した。粘度(20℃)のデータを表2に示す。
[Mixing test with titanium oxide]
Hydrophobized titanium oxide (STR-100A-LP, manufactured by Sakai Chemical Industry Co., Ltd.) 40 parts, decamethylcyclopentasiloxane (KF-995, manufactured by Shin-Etsu Chemical Co., Ltd.) 6 parts, polyether-modified silicone (KF-6038, Shin-Etsu) Chemical Co., Ltd.) and 100 parts of φ0.5 mm zirconia beads were placed in a mayonnaise bottle, mixed, and then treated with a paint shaker (manufactured by Red Devil) for 1 hour. A titanium oxide dispersion was obtained by separating the beads. The specific surface area (BET method) of the raw material titanium oxide particles before the surface treatment is a spindle shape of 100 m 2 / g (average primary particle diameter is 0.02 μm for the minor axis and 0.1 μm for the major axis), and the silica layer Was 8% by weight with respect to the total amount of particles after treatment, the aluminum hydroxide layer was 4% by weight with respect to the total amount of particles after treatment, and the silicone layer was 4% by weight with respect to the total amount of particles after treatment. 30 g of the zinc oxide dispersion produced in each of Examples 1 to 3 and Comparative Examples 1 and 2 was placed in a 50 ml screw bottle, and 30 g of the resulting titanium oxide dispersion was added thereto. Thereafter, the mixture was shaken up and down 100 times to obtain a mixture of zinc oxide dispersion and titanium oxide dispersion. Using a B-type viscometer (manufactured by Tokyo Keiki Co., Ltd.), rotor No. 3 was used, and the viscosity 60 seconds after the start of rotation was measured. The viscosity (20 ° C.) data is shown in Table 2.
疎水化処理酸化チタン(STR−100C−LP、堺化学工業社製)40部、デカメチルシクロペンタシロキサン(KF−995、信越化学工業社製)6部、ポリエーテル変性シリコーン(KF−6038、信越化学工業社製)及びφ0.5mmジルコニアビーズ100部をマヨネーズ瓶に入れ、混合した後、ペイントシェーカー(レッドデビル社製)で1時間処理した。ビーズを分離することで酸化チタン分散体を得た。なお、表面処理前の原料酸化チタン粒子の比表面積(BET法)は、100m2/gの紡錘状(平均一次粒子径は短径が0.02μm、長径が0.1μm)であり、水酸化アルミニウム層は処理後の粒子全量に対して7重量%、シリコーン層は処理後の粒子全量に対して4重量%であった。50mlのスクリュー瓶に実施例1で作製した酸化亜鉛分散体を30g入れ、そこに得られた酸化チタン分散体を30g添加した。その後、100回上下に振り混ぜ酸化亜鉛分散体と酸化チタン分散体の混合物を得た。酸化チタン分散体及び混合物をB型粘度計(東京計器社製)でローターNo.3を使用し、回転開始から60秒後の粘度を測定した。粘度(20℃)のデータを表3に示す。 Hydrophobized titanium oxide (STR-100C-LP, manufactured by Sakai Chemical Industry Co., Ltd.) 40 parts, Decamethylcyclopentasiloxane (KF-995, manufactured by Shin-Etsu Chemical Co., Ltd.) 6 parts, Polyether-modified silicone (KF-6038, Shin-Etsu) Chemical Co., Ltd.) and 100 parts of φ0.5 mm zirconia beads were placed in a mayonnaise bottle, mixed, and then treated with a paint shaker (manufactured by Red Devil) for 1 hour. A titanium oxide dispersion was obtained by separating the beads. The specific surface area (BET method) of the raw material titanium oxide particles before the surface treatment is a spindle shape of 100 m 2 / g (average primary particle diameter is 0.02 μm for the minor axis and 0.1 μm for the major axis). The aluminum layer was 7% by weight based on the total amount of particles after treatment, and the silicone layer was 4% by weight based on the total amount of particles after treatment. 30 g of the zinc oxide dispersion prepared in Example 1 was put in a 50 ml screw bottle, and 30 g of the obtained titanium oxide dispersion was added thereto. Thereafter, the mixture was shaken up and down 100 times to obtain a mixture of zinc oxide dispersion and titanium oxide dispersion. Using a B-type viscometer (manufactured by Tokyo Keiki Co., Ltd.), rotor No. 3 was used, and the viscosity 60 seconds after the start of rotation was measured. The viscosity (20 ° C.) data is shown in Table 3.
疎水化処理酸化チタン(STR−100W−LP、堺化学工業社製)40部、デカメチルシクロペンタシロキサン(KF−995、信越化学工業社製)6部、ポリエーテル変性シリコーン(KF−6038、信越化学工業社製)及びφ0.5mmジルコニアビーズ100部をマヨネーズ瓶に入れ、混合した後、ペイントシェーカー(レッドデビル社製)で1時間処理した。ビーズを分離することで酸化チタン分散体を得た。なお、表面処理前の原料酸化チタン粒子の比表面積(BET法)は、100m2/gの紡錘状(平均一次粒子径は短径が0.02μm、長径が0.1μm)であり、シリカ層は処理後の粒子全量に対して10重量%、シリコーン層は処理後の粒子全量に対して4重量%であった。50mlのスクリュー瓶に実施例1で作製した酸化亜鉛分散体を30g入れ、そこに得られた酸化チタン分散体を30g添加した。その後、100回上下に振り混ぜ酸化亜鉛分散体と酸化チタン分散体の混合物を得た。酸化チタン分散体及び混合物をB型粘度計(東京計器社製)でローターNo.3を使用し、回転開始から60秒後の粘度を測定した。粘度(20℃)のデータを表4に示す。 Hydrophobized titanium oxide (STR-100W-LP, manufactured by Sakai Chemical Industry Co., Ltd.) 40 parts, decamethylcyclopentasiloxane (KF-995, manufactured by Shin-Etsu Chemical Co., Ltd.) 6 parts, polyether-modified silicone (KF-6038, Shin-Etsu) Chemical Co., Ltd.) and 100 parts of φ0.5 mm zirconia beads were placed in a mayonnaise bottle, mixed, and then treated with a paint shaker (manufactured by Red Devil) for 1 hour. A titanium oxide dispersion was obtained by separating the beads. The specific surface area (BET method) of the raw material titanium oxide particles before the surface treatment is a spindle shape of 100 m 2 / g (average primary particle diameter is 0.02 μm for the minor axis and 0.1 μm for the major axis), and the silica layer Was 10% by weight based on the total amount of particles after treatment, and the silicone layer was 4% by weight based on the total amount of particles after treatment. 30 g of the zinc oxide dispersion prepared in Example 1 was put in a 50 ml screw bottle, and 30 g of the obtained titanium oxide dispersion was added thereto. Thereafter, the mixture was shaken up and down 100 times to obtain a mixture of zinc oxide dispersion and titanium oxide dispersion. Using a B-type viscometer (manufactured by Tokyo Keiki Co., Ltd.), rotor No. 3 was used, and the viscosity 60 seconds after the start of rotation was measured. The viscosity (20 ° C.) data is shown in Table 4.
表2、表3及び表4の結果より、実施例1〜3と酸化チタン分散体との混合物では増粘は見られないが、比較例1、2と酸化チタン分散体との混合物では増粘した。 From the results of Table 2, Table 3 and Table 4, thickening is not observed in the mixture of Examples 1 to 3 and the titanium oxide dispersion, but thickening is observed in the mixture of Comparative Examples 1 and 2 and the titanium oxide dispersion. did.
本発明により、酸化亜鉛粒子を含有する組成物の増粘を防止することができ、これによって、酸化亜鉛粒子を化粧料に安定して配合することができるものである。 According to the present invention, thickening of a composition containing zinc oxide particles can be prevented, and thereby zinc oxide particles can be stably blended in cosmetics.
Claims (7)
A cosmetic obtained by blending the zinc oxide dispersion according to claim 1, 2, 3, 4, 5 or 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011115519A JP2012240995A (en) | 2011-05-24 | 2011-05-24 | Zinc oxide dispersion and cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011115519A JP2012240995A (en) | 2011-05-24 | 2011-05-24 | Zinc oxide dispersion and cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2012240995A true JP2012240995A (en) | 2012-12-10 |
Family
ID=47463069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011115519A Pending JP2012240995A (en) | 2011-05-24 | 2011-05-24 | Zinc oxide dispersion and cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2012240995A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016141671A (en) * | 2015-02-05 | 2016-08-08 | 株式会社ノエビア | Water-in-oil emulsified cosmetic for protection from ultraviolet |
| US20210315781A1 (en) * | 2018-10-24 | 2021-10-14 | Tayca Corporation | Inorganic powder composite, method for producing same, water-in-oil emulsion composition, and sunscreen cosmetic |
| WO2022138486A1 (en) * | 2020-12-25 | 2022-06-30 | 株式会社 資生堂 | Oil-in-water type emulsion cosmetic |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11302015A (en) * | 1998-02-20 | 1999-11-02 | Sakai Chem Ind Co Ltd | Zinc oxide particle composition having controlled surface activity, its production and cosmetic containing the same |
| JP2001058934A (en) * | 1999-08-19 | 2001-03-06 | Shiseido Co Ltd | Antisuntan cosmetic |
| JP2002060329A (en) * | 2000-08-16 | 2002-02-26 | Shiseido Co Ltd | Sunscreening cosmetic |
| JP2004002887A (en) * | 2003-07-28 | 2004-01-08 | Noevir Co Ltd | Pigment dispersion and cosmetics |
| JP2005154736A (en) * | 2003-11-05 | 2005-06-16 | Shiseido Co Ltd | Powder dispersion stabilizing agent and cosmetic blended with the agent |
| JP2007022972A (en) * | 2005-07-19 | 2007-02-01 | Toyo Ink Mfg Co Ltd | Pigment dispersion, method for producing the same, and cosmetics using the same |
| JP2010143852A (en) * | 2008-12-18 | 2010-07-01 | Shiseido Co Ltd | Titanium oxide dispersion and cosmetic blended with the same |
-
2011
- 2011-05-24 JP JP2011115519A patent/JP2012240995A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11302015A (en) * | 1998-02-20 | 1999-11-02 | Sakai Chem Ind Co Ltd | Zinc oxide particle composition having controlled surface activity, its production and cosmetic containing the same |
| JP2001058934A (en) * | 1999-08-19 | 2001-03-06 | Shiseido Co Ltd | Antisuntan cosmetic |
| JP2002060329A (en) * | 2000-08-16 | 2002-02-26 | Shiseido Co Ltd | Sunscreening cosmetic |
| JP2004002887A (en) * | 2003-07-28 | 2004-01-08 | Noevir Co Ltd | Pigment dispersion and cosmetics |
| JP2005154736A (en) * | 2003-11-05 | 2005-06-16 | Shiseido Co Ltd | Powder dispersion stabilizing agent and cosmetic blended with the agent |
| JP2007022972A (en) * | 2005-07-19 | 2007-02-01 | Toyo Ink Mfg Co Ltd | Pigment dispersion, method for producing the same, and cosmetics using the same |
| JP2010143852A (en) * | 2008-12-18 | 2010-07-01 | Shiseido Co Ltd | Titanium oxide dispersion and cosmetic blended with the same |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016141671A (en) * | 2015-02-05 | 2016-08-08 | 株式会社ノエビア | Water-in-oil emulsified cosmetic for protection from ultraviolet |
| US20210315781A1 (en) * | 2018-10-24 | 2021-10-14 | Tayca Corporation | Inorganic powder composite, method for producing same, water-in-oil emulsion composition, and sunscreen cosmetic |
| US12156924B2 (en) * | 2018-10-24 | 2024-12-03 | Tayca Corporation | Inorganic powder composite, method for producing same, water-in-oil emulsion composition, and sunscreen cosmetic |
| WO2022138486A1 (en) * | 2020-12-25 | 2022-06-30 | 株式会社 資生堂 | Oil-in-water type emulsion cosmetic |
| JP2022101857A (en) * | 2020-12-25 | 2022-07-07 | 株式会社 資生堂 | Oil-in-water type emulsion cosmetic |
| JP7790867B2 (en) | 2020-12-25 | 2025-12-23 | 株式会社 資生堂 | Oil-in-water emulsion cosmetics |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5910632B2 (en) | Composite powder and method for producing the same | |
| JP6627833B2 (en) | Water dispersion | |
| JP5929920B2 (en) | Surface-treated zinc oxide powder, antibacterial agent and antibacterial composition | |
| JP5365763B1 (en) | Plate-like integrated spherical zinc oxide particles, production method thereof, cosmetics and heat-dissipating filler | |
| JP7404651B2 (en) | Oil-in-water emulsion cosmetic and method for producing the same | |
| JP6291732B2 (en) | Method for producing composite powder dispersion | |
| JP7695502B2 (en) | Zinc oxide particle dispersion and cosmetic preparation containing same | |
| JP5983086B2 (en) | Cosmetics | |
| JP6802629B2 (en) | Aqueous dispersions, cosmetics and their manufacturing methods | |
| JP5910090B2 (en) | Composite powder, cosmetics and ink | |
| WO2016121761A1 (en) | Dispersion, production method therefor, and cosmetic | |
| JP5907248B2 (en) | Zinc carbonate salt particles, zinc oxide particles, production method thereof, heat dissipating filler and cosmetic | |
| JP2012240995A (en) | Zinc oxide dispersion and cosmetic | |
| JP6051759B2 (en) | Method for producing titanium oxide particles for cosmetics | |
| JP6051776B2 (en) | Rare earth doped barium sulfate and cosmetics | |
| JP7695503B2 (en) | Titanium dioxide particle dispersion and cosmetic preparation containing same | |
| JP2014201465A (en) | Zinc oxide particle, dispersion and cosmetic | |
| JP2004339326A (en) | Viscous liquid composition, method for producing the same and cosmetic | |
| JP2023147613A (en) | Aqueous dispersion and cosmetics | |
| WO2016121760A1 (en) | Dispersion | |
| EP4620453A1 (en) | Aqueous dispersion of surface-hydrophobized inorganic powder and cosmetic preparation containing same | |
| EP4682106A1 (en) | Fatty acid-treated zinc oxide particles, method for producing same, and dispersion and cosmetic having same blended therein | |
| JP2023147614A (en) | Oil-based dispersions and cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140221 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141029 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141125 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150114 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150714 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20151117 |